Expression and regulation of stromelysin and matrilysin by growth factors and oncogenes.
Expression and regulation of stromelysin and matrilysin by growth factors and oncogenes.
复制标题
生长因子和癌基因对基质溶解素和基质溶解素的表达和调节。
DOI:
10.1042/bst0220058
复制
发表时间:
1994
影响因子:
3.9
通讯作者:
Matrisian,LM
中科院分区:
文献类型:
--
作者:
McDonnell,S;Wright,JH;Gaire,M;Matrisian,LM
A major characteristic of malignant cells is their ability to invade the normal tissues surrounding them and metastasize to distant sites in the body. It is the metastatic nature of malignant cells that presents the greatest challenge to clinicians in terms of treatment, since the tumour is no longer localized to one area. The process of tumour invasion and metastasis is extremely complex and involves a series of sequential steps, many of which we can now begin to explore in detail at the cellular and molecular level. It is an arduous, multistep process in which only a small proportion of the tumour cells survive to start a new tumour. First, cells detach from the primary tumour and move into the blood vessels that nourish it. They are then carried in the general circulation until they lodge in a capillary bed. Cells that survive this trip may then penetrate the blood vessel cell wall, invade the surrounding tissues and begin to proliferate and form a new tumour mass. As can be seen from the above scenario, tumour cells must manifest invasive properties at several points: to enter and escape the circulation and to penetrate into normal tissues [11. This breaking down of tissue barriers is accomplished by the elaboration of specific enzymes which degrade the proteins of the extracellular matrix that make up basement membranes and stromal components of tissues. There are four main classes of proteases involved in proteolytic degradation of the extracellular matrix [2]: serine proteases, cysteine proteases, aspartyl proteases and metalloproteinases. It is generally thought that these enzymes degrade local tissues through which tumour cells invade, and that they may also be involved in penetration through the basement membrane during the extravasation of tumour cells from blood vessels [3, 4].Abbreviations used: MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase; DMBA, dimethylbenz [a] anthracene; PMA, phorbol 12-myristate 13-acetate; TRE, TPA responsive element; AP-1, activa-tor protein-1; TIE, TGF-/3, inhibitory element; EGF, epi-dermal growth factor; PEA-3, polyoma enhancer A binding protein-3.